dog |
LD50 |
oral |
> 3gm/kg (3000mg/kg) |
GASTROINTESTINAL: NAUSEA OR VOMITING |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
mouse |
LD50 |
intraperitoneal |
65mg/kg (65mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: PERITONITIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
mouse |
LD50 |
intravenous |
> 45mg/kg (45mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
mouse |
LD50 |
oral |
2550mg/kg (2550mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
rat |
LD50 |
intraperitoneal |
108mg/kg (108mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
GASTROINTESTINAL: PERITONITIS |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
rat |
LD50 |
intravenous |
> 45mg/kg (45mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |
rat |
LD50 |
oral |
4400mg/kg (4400mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD |
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19(Suppl, |